The Characterization of Individual Patient Placebo Response: Impact on the Clinical Study Power

Dominique Demolle serves as Chief Executive Officer of Tools4Patient since its inception in 2013. Dr. Demolle holds a Ph.D. in Biochemistry from the University of Brussels. She joined the Clinical Research Group of GD Searle and then Eli Lilly. She has held positions with increasing leadership responsibilities at Eli Lilly and Company with the Lilly Indianapolis Clinical Research Unit in the US and the European Operational Staff management and ultimately became the Associate Director of Global Early Phase Operations. In 2007 she co-founded and successfully developed a Consulting Clinical Research Organization including partnerships with pharma and biotech before she left to set up Tools4Patient with previous colleagues.